BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33585655)

  • 1. The role of high-flow nasal therapy in bronchiectasis: a
    Good WR; Garrett J; Hockey HUP; Jayaram L; Wong C; Rea H
    ERJ Open Res; 2021 Jan; 7(1):. PubMed ID: 33585655
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.
    Lee AL; Burge AT; Holland AE
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011699. PubMed ID: 28952156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity].
    Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282
    [No Abstract]   [Full Text] [Related]  

  • 4. The BED-Pro Tool: facilitating the detection of bronchiectasis exacerbations.
    Gao YH; Guan WJ
    ERJ Open Res; 2023 Jul; 9(3):. PubMed ID: 37143843
    [No Abstract]   [Full Text] [Related]  

  • 5. The impact of bronchiectasis associated to sinonasal disease on quality of life.
    Guilemany JM; Alobid I; Angrill J; Ballesteros F; Bernal-Sprekelsen M; Picado C; Mullol J
    Respir Med; 2006 Nov; 100(11):1997-2003. PubMed ID: 16581240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway clearance techniques for bronchiectasis.
    Lee AL; Burge AT; Holland AE
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008351. PubMed ID: 26591003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical utility of long-term humidification therapy in chronic airway disease.
    Rea H; McAuley S; Jayaram L; Garrett J; Hockey H; Storey L; O'Donnell G; Haru L; Payton M; O'Donnell K
    Respir Med; 2010 Apr; 104(4):525-33. PubMed ID: 20144858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial.
    Chalmers JD; Crichton ML; Brady G; Finch S; Lonergan M; Fardon TC
    BMC Pulm Med; 2019 May; 19(1):85. PubMed ID: 31060529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway clearance techniques for bronchiectasis.
    Lee AL; Burge A; Holland AE
    Cochrane Database Syst Rev; 2013 May; (5):CD008351. PubMed ID: 23728674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis.
    Diego AD; Milara J; Martinez-Moragón E; Palop M; León M; Cortijo J
    Respirology; 2013 Oct; 18(7):1056-62. PubMed ID: 23714268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis.
    Laska IF; Crichton ML; Shoemark A; Chalmers JD
    Lancet Respir Med; 2019 Oct; 7(10):855-869. PubMed ID: 31405826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of airway clearance techniques in patients experiencing an acute exacerbation of bronchiectasis: a systematic review.
    Phillips J; Lee A; Pope R; Hing W
    Physiother Theory Pract; 2020 Dec; 36(12):1300-1315. PubMed ID: 30776932
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between Symptoms, Exacerbations, and Treatment Response in Bronchiectasis.
    Gao YH; Abo Leyah H; Finch S; Lonergan M; Aliberti S; De Soyza A; Fardon TC; Tino G; Chalmers JD
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1499-1507. PubMed ID: 32097051
    [No Abstract]   [Full Text] [Related]  

  • 14. Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD.
    Ronco R; Franco G; Monzio Compagnoni M; Aliberti S; Luppi F; Corrao G; Faverio P
    ERJ Open Res; 2023 Jul; 9(4):. PubMed ID: 37529638
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients hospitalized with an infective exacerbation of bronchiectasis unrelated to cystic fibrosis: Clinical, physiological and sputum characteristics.
    Venning V; Bartlett J; Jayaram L
    Respirology; 2017 Jul; 22(5):922-927. PubMed ID: 28236369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of exacerbations in patients with stable non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis of pharmacological and non-pharmacological therapies.
    Abu Dabrh AM; Hill AT; Dobler CC; Asi N; Farah WH; Haydour Q; Wang Z; Benkhadra K; Prokop LJ; Murad MH
    BMJ Evid Based Med; 2018 Jun; 23(3):96-103. PubMed ID: 29678900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
    Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term nasal intermittent positive pressure ventilation (NIPPV) in sixteen consecutive patients with bronchiectasis: a retrospective study.
    Gacouin A; Desrues B; Léna H; Quinquenel ML; Dassonville J; Delaval P
    Eur Respir J; 1996 Jun; 9(6):1246-50. PubMed ID: 8804945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of physiotherapy practice for people with bronchiectasis.
    Lee AL; Baenziger S; Louey A; Jennings S; Solin P; Hoy R
    ERJ Open Res; 2021 Apr; 7(2):. PubMed ID: 34109238
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of periodontal treatment on exacerbation frequency and lung function in patients with chronic periodontitis: study protocol of a 1-year randomized controlled trial.
    Romero SS; Pinto EH; Longo PL; Dal Corso S; Lanza FC; Stelmach R; Rached SZ; Lino-Dos-Santos-Franco A; Mayer MP; Bussadori SK; Fernandes KP; Mesquita-Ferrari RA; Horliana AC
    BMC Pulm Med; 2017 Jan; 17(1):23. PubMed ID: 28114928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.